Latest Posts

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY

Meet us in Paris to interact with key opinion leaders and learn first-hand about practice challenges and controversies in oncology.

Participants:

– Dr. Mads Dalgaard – Chief Executive Officer, Cureteq AG

– Ph.D. Marie-Christine Bissery – Chief Science Officer, Cureteq AG

– Dr. Stephan Braun – Chief Medical Officer – Cureteq AG

– Prof. Dr. Dr. med. Juergen Scheele – Chief Medical Officer, Innoplexus AG

– Ms. Dafina Taqi – Support Project Manager, Innoplexus AG

– Ms. Claudia M. Hausoel – Chief Marketing Officer, Innoplexus AG

– Ms. Eleni Zisimopoulou – Medical Information Specialist, Innoplexus AG

Date: September 09-13, 2022

Venue: Expo Porte de Versailles, Paris France

Read more

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY